Verve Therapeutics, Inc. Operating Lease, Liability in USD from Q3 2021 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Verve Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2021 to Q1 2025.
Verve Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2025 was $68.6M, a 6.84% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Verve Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$68.6M	-$5.04M	-6.84%	Mar 31, 2025	10-Q	2025-05-14
Q4 2024	$70M	-$4.92M	-6.57%	Dec 31, 2024	10-K	2025-02-27
Q3 2024	$71.3M	-$5.55M	-7.23%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$72.5M	-$5.39M	-6.92%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$73.7M	-$6.44M	-8.04%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$74.9M	-$7.01M	-8.56%	Dec 31, 2023	10-K	2024-02-27
Q3 2023	$76.8M	-$3.39M	-4.23%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$77.9M	-$30.2M	-28%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$80.1M	-$28.8M	-26.4%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$81.9M	-$26.8M	-24.7%	Dec 31, 2022	10-K	2023-03-02
Q3 2022	$80.2M	-$28.6M	-26.3%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$108M			Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$109M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$109M			Dec 31, 2021	10-K	2022-03-14
Q3 2021	$109M			Sep 30, 2021	10-Q	2021-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.